Stock listing

NASDAQ:ALBO Albireo Pharma Inc Stock

Follow Albireo Pharma Inc into a list and get an email when it puts out news.

Last close · NASDAQ:ALBO

$44.15 USD

Close on Mar 2, 2023 · No longer trades

Nov 4, 2016 to last close +201.8% · weekly closes, Nov 4, 2016 – Mar 2, 2023
Lowest – highest close
$11.67 – $44.95 USDSince Nov 4, 2016 · lowest Mar 16, 2020 · highest Feb 3, 2023

Delisted NASDAQ:ALBO no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:ALBO
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Albireo Pharma Inc on 6ix

Calls
8 calls with a replay · 8 with a transcript · latest Nov 8, 2022
Decks
8 decks · latest Oct 11, 2022

Events

CallWhenStatus
Albireo Pharma (ALBO) Q3 2022 Earnings CallTue, Nov 08, 2022 · 4:30 PM ETReplay
Albireo Pharma (ALBO) Q2 2022 Earnings CallMon, Aug 15, 2022 · 4:30 PM ETReplay
Albireo Pharma (ALBO) Q1 2022 Earnings CallMon, May 16, 2022 · 4:30 PM ETReplay
Albireo Pharma (ALBO) Q4 2021 Earnings CallTue, Mar 01, 2022 · 10:00 AM ETReplay
Albireo Pharma (ALBO) Q3 2021 Earnings CallThu, Nov 04, 2021 · 10:00 AM ETReplay
Albireo Pharma (ALBO) Q2 2021 Earnings CallThu, Aug 05, 2021 · 10:00 AM ETReplay
Albireo Pharma (ALBO) Q1 2021 Earnings CallThu, May 06, 2021 · 10:00 AM ETReplay
Albireo Pharma (ALBO) Q4 2020 Earnings CallThu, Feb 25, 2021 · 10:00 AM ETReplay

Open Events

Decks

DeckKindSlidesDate
Corporate Update (October 2022)Corporate update18 slidesOct 11, 2022
Investor Presentation (December 2016)Investor deck40 slidesDec 21, 2016
Biodel — Merger or Acquisition (October 2016)Merger or acquisition49 slidesOct 11, 2016
Biodel — Merger or Acquisition (October 2016)Merger or acquisition43 slidesOct 11, 2016
Biodel — Merger or Acquisition (September 2016)Merger or acquisition45 slidesSep 22, 2016
Biodel — Merger or Acquisition (May 2016)Merger or acquisition41 slidesMay 25, 2016
Biodel — Technical Presentation (March 2015)Technical12 slidesMar 16, 2015
Biodel — Investor Presentation (October 2014)Investor deck42 slidesOct 27, 2014

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Habib Joseph Dable
Other companies: Tyra Biosciences, Inc. (Director · Since at least Apr 16, 2026); SpyGlass Pharma, Inc. (Director · Since at least Feb 5, 2026); Relay Therapeutics, Inc. (Director · Since at least Nov 4, 2025); Day One Biopharmaceuticals Inc (Director · Since at least Jan 17, 2024); PepGen Inc. (Director · Since at least Sep 20, 2022); Blueprint Medicines Corp (Director · Since at least Jun 23, 2022); Jade Biosciences, Inc. (Director · Jul 10, 2023 – Jun 5, 2024 · Past); Acceleron Pharma Inc (CEO and President, Director · Jan 4, 2021 – Nov 19, 2021 · Past)
Director · Aug 8, 2022 – Mar 2, 2023 · Past
Heather Preston
Other companies: Oxford Nanopore Technologies PLC (Non Executive Director · Since at least May 1, 2026); Aligos Therapeutics, Inc. (Director · Since at least Aug 7, 2024); Akouos Inc (Director · Jun 25, 2020 – Nov 30, 2022 · Past); Fusion Pharmaceuticals Inc (Director · Jun 25, 2020 – Jun 14, 2023 · Past); Karuna Therapeutics Inc (Director · Jun 27, 2019 – Jun 24, 2021 · Past); Entasis Therapeutics Holdings Inc (Director · Sep 25, 2018 – Jun 19, 2019 · Past); Otonomy Inc (Director · Aug 12, 2014 – Jun 11, 2019 · Past); Alder BioPharmaceuticals Inc (Director · May 7, 2014 – Oct 22, 2019 · Past)
Director · Nov 3, 2016 – Jan 23, 2017 · Past
Charles A Sanders
Other companies: LipoScience Inc (Director · Jan 24, 2013 – Jan 30, 2013 · Past); BioCryst Pharmaceuticals, Inc. (Director · Dec 8, 2009 – Feb 29, 2016 · Past); Cephalon Inc (Director · May 12, 2009 – May 20, 2010 · Past); Vertex Pharmaceuticals Incorporated (Director · May 4, 2009 – Jun 1, 2010 · Past); Genentech Inc (Director · Mar 26, 2009 – Mar 26, 2009 · Past); Icagen Inc (Director · Mar 5, 2009 – Sep 2, 2011 · Past)
Director · Mar 3, 2009 – Mar 8, 2012 · Past
Pamela Stephenson
Other companies: Disc Medicine, Inc. (Chief Commercial Officer · Since at least Feb 26, 2024); Zynerba Pharmaceuticals Inc (Director · Jun 14, 2022 – Oct 10, 2023 · Past)
Chief Commercial Officer · Apr 22, 2022 – Mar 2, 2023 · Past
Patrick Taylor Horn
Other companies: Fulcrum Therapeutics, Inc. (Chief Medical Officer · Mar 18, 2024 – Mar 18, 2024 · Past); Tetraphase Pharmaceuticals Inc (Chief Medical Officer · May 15, 2013 – Jun 13, 2017 · Past)
Chief Medical Officer · Aug 6, 2018 – Oct 22, 2021 · Past
Craig Hopkinson
Other companies: Alkermes plc (Executive Vice President, Research & Development and Chief Medical Officer · Since at least Jun 7, 2019)
Director · Dec 1, 2022 – Mar 2, 2023 · Past
Jason Duncan
Other companies: Neumora Therapeutics, Inc. (See Remarks · Since at least Dec 11, 2023)
Chief Legal Officer and GC · Jun 4, 2018 – Mar 2, 2023 · Past
Julia R Brown
Other companies: Gyre Therapeutics, Inc. (Director · May 12, 2010 – Aug 14, 2015 · Past)
Director · Apr 24, 2012 – Jun 7, 2018 · Past
Martha J Carter
Other companies: Aegerion Pharmaceuticals Inc (See Remarks · Aug 4, 2015 – May 9, 2016 · Past)
Chief Regulatory Officer · Nov 28, 2016 – Mar 2, 2023 · Past
Peter A Zorn
Other companies: Gyre Therapeutics, Inc. (SVP, Lgl Affrs, GC & Secretary · Dec 19, 2007 – Jan 17, 2013 · Past)
Chief Corp. Officer, GC & Sec · Nov 3, 2016 – Aug 21, 2017 · Past
All 15 people
PersonSeat
Anne KlibanskiDirector · Jun 8, 2018 – Jun 24, 2021 · Past
Barry H GinsbergDirector · Jun 11, 2008 – Feb 24, 2016 · Past
Erik SteinerVice-President, Operations · Dec 14, 2010 – Dec 23, 2013 · Past
Jan MattssonChief Scientific Officer · Nov 3, 2016 – Mar 2, 2023 · Past
Susan AlesinaDirector · Aug 8, 2022 – Mar 2, 2023 · Past

Open People

Log in to ask 6ix AI your own questions about Albireo Pharma Inc.